Purchases and Sales Made in Q4 2024 in Xeris Biopharma Holdings, Inc. (XERS)
This table provides information about the institutional ownership of Xeris Biopharma Holdings, Inc. (XERS) during Q4 2024. The information is specifically focused on institutions that hold shares of Xeris Biopharma Holdings, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
34.5K+ 57.26% |
$95.8K - $129K
|
94.7K
$333K
|
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
12.3KNew |
$34.2K - $46K
|
12.3K
$43.4K
|
|
|
Jan 17, 2025
Q4 2024
|
Goldstein Advisors, LLC
Madison, WI |
BUY
|
- |
7.38K+ 24.24% |
$20.5K - $27.5K
|
37.8K
$133K
|
|
|
Jan 17, 2025
Q4 2024
|
Janney Montgomery Scott LLC
|
BUY
|
- |
5.5K+ 31.43% |
$15.3K - $20.5K
|
23K
$81K
|
|
|
Jan 24, 2025
Q4 2024
|
Gps Wealth Strategies Group, LLC
|
BUY
|
- |
3.9K+ 6.19% |
$10.8K - $14.5K
|
66.9K
$236K
|
|
|
Jan 23, 2025
Q4 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
2.95K+ 10.31% |
$8.21K - $11K
|
31.6K
$111K
|
|
|
Jan 10, 2025
Q4 2024
|
Wealth Enhancement Advisory Services, LLC
|
BUY
|
- |
254+ 2.04% |
$706 - $947
|
12.7K
$44.6K
|